摘要 |
PROBLEM TO BE SOLVED: To provide a Leukemia therapeutic agent, Leukemia cell growth inhibitor, hematopoietic stem cell transplantation pretreatment agent, and determining method of effect.SOLUTION: FASN inhibitor is useful as a leukemia therapeutic agent and the like because of an action which inhibits proliferation of leukemia cell having at least either one fusion gene of a NUP98 fusion gene, CALM fusion gene, and AF10 fusion gene. By the leukemia therapeutic agent and the like, it is useful for the treatment of leukemia which has at least either one fusion gene of a NUP98 fusion gene, CALM fusion gene, and AF10 fusion gene, or hematopoietic stem cell transplantation. |